Regulatory T Cells in Inflammation


Book Description

Scientific interest in regulatory T cells has revived during the last decade. Initially described in the early seventies as suppressor T cells, the concept of suppressor/regulatory T cells went through turbulent times during the eighties when molecular analysis failed to identify putative suppressor genes. The constructive and elegant cellular experiments on regulatory T cells during the nineties, initiated by Shimon Sakaguchi and co-workers, however have brought these cells back into the limelight. Nowadays, regulatory T cells are regarded as essential components of the immune system, and several different subsets of regulatory T cells have been described. Considerable regulatory function has been attributed to the CD4+CD25+ T cell subset. These cells act by suppressing adaptive and possibly also innate immune responses thereby maintaining or restoring the balance between immunity and tolerance. The suppressive effects of CD4+CD25+ regulatory T cells are cell-contact dependent but a role for soluble factors, particularly in vivo, has been suggested as well. The aim of this book is to bring together recent developments and viewpoints in the field of CD4+CD25+ regulatory T cells and to discuss the potential use of regulatory T cells in immunotherapy of inflammatory diseases. By linking data on regulatory T cells from experimental models with recent findings from the clinic, this topical book will be of interest to immunologists and other biomedical researchers as well as clinicians that are interested in regulation and manipulation of the immune response during (chronic) inflammatory disease.




CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential


Book Description

The vertebrate immune system defends the organism against invading pathogens while at the same time being self-tolerant to the body’s own constituents thus preserving its integrity. Multiple mechanisms work in concert to ensure self-tolerance. Apart from purging the T cell repertoire from auto-reactive T cells via negative selection in the thymus dominant tolerance exerted by regulatory T cells plays a major role in tolerance imposition and maintenance. Among the various regulatory/suppressive cells hitherto described, CD4+CD25+ regulatory T cells (Treg) and interleukin-10 producing T regulatory 1 (Tr1) cells have been studied in most detail and are the subject of most articles in this issue. Treg, also called "natural" regulatory T cells, will be traced from their intra-thymic origin to the site of their action in peripheral lymphoid organs and tissues. The repertoire of Treg is clearly biased towards recognition of self-antigens, thereby potentially preventing autoimmune diseases such as gastritis and oophoritis. Regulatory T cells, however also control infections, allergies and tolerance to transplanted tissues and this requires their induction in the periphery under conditions which are not yet fully understood. The concept of dominant tolerance, by far not novel, will offer new insights and hopefully tools for the successful treatment of autoimmune diseases, improved cancer immunotherapy and transplant survival. The fulfillment of these high expectations will, however, require their unambiguous identification and a better understanding of their mode of action.




Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?


Book Description

This Research Topic is a call for papers to provide an up to date assessment of current attempts to introduce tolerogenic therapies into clinical practice. Tolerance has been a highly sought after goal in the field of organ transplantation for over half a century, and is now readily achievable in rodent models, but considerable barriers remain to successfully translating tolerogenic treatments to the clinic. The initial call for this Research Topic has been aimed to provide an overview of recent advances made within the European RISET and American ITN networks with regard to tolerogenic strategies in clinical transplantation, autoimmune disease, and allergy. Articles will also cover the barriers to clinical tolerance induction and new emerging approaches to overcome such barriers. 1. Collaborative networks working towards the goal of therapeutic tolerance induction 2. Prope tolerance and minimization of immunosuppression 3. Lessons from operationally tolerant patients 4. Targeted withdrawal of immunosuppression 5. Stem cells and hematopoietic chimerism as a route to tolerance 6. Promoting regulatory T cells 7. Tolerogenic dendritic cells and negative vaccination 8. Inhibitory pathways and mechanisms in tolerance 9. Memory T cells and heterologous immunity 10. The innate response to allotransplants 11. Chronic graft loss--what are the missing links? 12. The impact of graft microenvironment on tolerance







Regulatory T Cells and Clinical Application


Book Description

Covering one of the hottest topics in immunology today, this book provides a comprehensive view of all types of regulatory T cells described so far in the literature. The book will have broad appeal to both researchers and clinicians.




Mechanisms of CD8 T Cell Peripheral Tolerance to Cross-presented Self-antigen and Soluble Peptide in Vivo


Book Description

During T cell development, most cells with high avidity for self-antigen are deleted in the thymus through a process termed negative selection or central tolerance. However, due to variations in the level of antigen expression and availability, not all auto-reactive T cells may encounter their cognate antigen under the proper conditions to promote their elimination. Therefore, additional mechanisms are required to induce tolerance in the peripheral lymphoid organs such as the lymph nodes and spleen. This, process, called peripheral tolerance, provides another level of protection against the activation of auto-reactive T cells. T cell peripheral tolerance occurs through a variety of mechanisms including clonal elimination, the induction of non-responsiveness, TCR down-regulation, increased expression of negative signaling molecules, or immuno-regulation. Importantly, recent studies have demonstrated that defects in either central or peripheral T cell tolerance can contribute to the development of autoimmune diseases, such as type 1 diabetes and multiple sclerosis. Consequently, it is critical to understand the mechanisms underlying T cell peripheral tolerance in order to develop better therapies for the treatment and prevention of autoimmunity. To this end, the mechanisms promoting CD8 T cell peripheral tolerance to both cross-presented self-antigen and soluble peptide were examined. The deletion of naïve CD8 T cells following tolerogenic stimulation was found to occur independently of a death signal and, rather, required the sustained presence of antigen. Further studies revealed that depending upon the dose and kinetics of antigen treatment, tolerized CD8 T cells could undergo either apoptotic death or become functionally non-responsive, or anergic. The induction and maintenance of anergy required high levels of persistent antigenic stimulation and correlated with the down-regulation of TCR-mediated signaling molecules. In contrast, low levels of chronic antigen stimulation led to clonal elimination of the responding T cells. These data provide insight into the role of chronic antigen in the induction of CD8 T cell peripheral tolerance. Finally, the mechanism of naïve CD8 T cell deletion during peripheral tolerance was found to occur via an intrinsic apoptotic mechanism that could be inhibited by expression of the anti-apoptotic molecule, Bcl-2.